Loading...

Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian

Print Friendly, PDF & Email

A Conversation with Ultragenyx’s Chief Medical Officer, Camille Bedrosian to discuss Insights into Future LC-FAOD Research.  Also hear from Ultragenyx’s Global Metabolic Dietitian, Bridget Reineking on How to Use the Newly FDA Approved Medicine.

Date: 07/25/2020
Speaker:

Camille Bedrosian & Bridget Reineking


Listen Now: Click Here

Related Articles

MELAS Spectrum Disorders and Sonlicromanol: Progress Update
Date: 03/18/2022
Speaker:

Dr. Jan Smeitink


The Mito Disease Drug Development Journey
Date: 12/01/2021
Speaker:

Dr. Matthew Klein


Moving Mito Medicine: Reneo Strides Study
Date: 06/04/2021
Speaker:

Madhu Davies